MedLabs

MedLabs is a leading independent diagnostic laboratory offering a menu of more than 400 tests to over 3,000 physician and hospital customers. As one of the oldest, independent laboratories in the U.S., MedLabs provides a large, comprehensive menu of laboratory developed, esoteric, STAT and routine tests, which has been created through sixty-seven years of providing exceptional service that larger competitors are unable to match. The team of professionals at MedLabs, with the help of highly innovative diagnostic tests and proprietary software, give medical providers the ability to tackle today’s healthcare challenges and make a difference in the lives of millions of patients. The Company is headquartered in Cedar Knolls, New Jersey.

Transaction:

The transaction, completed in early 2018, allowed management to retain significant ownership post-close. The partnership also provided the necessary capital and resources for the business to continue to provide high quality services to existing customers, while establishing a growth plan including the expansion of its proprietary product portfolio in existing and new geographic territories, as well as future add-on acquisitions.

Opportunity:

Differentiated in the marketplace by high-quality customer service, faster turnaround times and a broad spectrum of routine and esoteric tests on par with the largest laboratories in the industry, MedLabs maintains a well-established foundation poised for significant expansion. In addition to the ability to broaden product offerings, other growth opportunities include geographic expansion and acquisitions. We expect the business to act as a platform for numerous add-on acquisitions that provide access to new geographies and complementary testing disciplines, further expanding MedLabs’ customer base.

Strategy:

Caymus Equity worked closely with management to establish a 100 Day Plan detailing how to best combine the resources of Caymus Equity with the existing successful platform. The strategic plan outlined the steps needed to achieve our growth objectives for the Company by continuing to expand the Company’s footprint.

CAYMUS EQUITY PARTNERS LLC

Securities Offered through Caymus Securities LLC, Member FINRA/SIPC

CONTACT INFO
ATLANTA

One Paces West
2727 Paces Ferry
Road SE, Suite 1650
Atlanta, GA 30339
T (404) 995-8300

NEW YORK

641 Lexington Avenue
17th Floor
New York, NY 10022
T (212) 755-3600